Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

100.89
-0.6411-0.63%
Post-market: 100.890.00000.00%16:15 EDT
Volume:413.92K
Turnover:41.72M
Market Cap:1.61B
PE:9.40
High:101.91
Open:101.51
Low:100.34
Close:101.53
52wk High:108.66
52wk Low:69.02
Shares:16.00M
Float Shares:16.00M
Volume Ratio:3.00
T/O Rate:2.59%
Dividend:1.47
Dividend Rate:1.45%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Reuters
·
32 mins ago

Health Rounds: New Dye for MRI Exams Detects Lung Cancer Earlier

Reuters
·
2 hours ago

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
3 hours ago

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
3 hours ago

U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo

Reuters
·
4 hours ago

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Yesterday

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Reuters
·
Yesterday

LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State

Reuters
·
Yesterday

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Yesterday

LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump

Reuters
·
Yesterday

Dow's Nearly 300-Point Fall Led by Losses in Johnson & Johnson, Nike Stocks

Dow Jones
·
Yesterday

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Yesterday

Johnson & Johnson Says Subcutaneous Cancer Treatment Study Shows Low Rates Across Key Events, Discontinuation

MT Newswires Live
·
Yesterday

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Yesterday

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
Yesterday

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
Yesterday

JNJ Reports Low Rates of Treatment-Related Events for Rybrevant Faspro Plus Lazcluze at Wclc 2026

Reuters
·
Yesterday

J&J - Fewer than 1% Discontinue Rybrevant Faspro Plus Lazcluze Due to Treatment-Related Events at One Year

THOMSON REUTERS
·
Yesterday

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

TIPRANKS
·
Yesterday

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday